NEWS OF THE WEEK
			HYDROGEN STORAGE Metal-organic frameworks hold promise as tailor-made hydrogen- storage materials.
			VENTURE CAPITAL Two universities establish funds to accelerate commercialization of research.
			EVERYBODY WINS New venture-capital group embraces employee/partner philosophy.
			SARS THERAPEUTICS Modeling identifies drug candidate to combat deadly syndrome.
			JAPANESE EARNINGS Clear business strategy benefited companies that posted gains.
			NANOSCALE ENGINEERING Lipid membranes are used to make nanoscale fluidic devices.
			PRICE-FIXING Crompton provides details of the investigations and lawsuits filed against it.
			FOOD FIGHT U.S. files complaint with WTO over genetically modified foods.
			CHEMICAL PLANT SECURITY Legislation stalls in Senate committee.

COVER STORY
			SYSTEMS BIOLOGY Interdisciplinary scientists model biological systems using expanding knowledge of cellular networks and molecular interactions.

BUSINESS
			BUSINESS CONCENTRATES
			CHEMICAL EARNINGS First-quarter earnings are a mixed bag.
			PHARMACEUTICAL EARNINGS Overall, drug companies' sales are up in first quarter, but earnings slip.
			BIOTECH EARNINGS Biopharm firms' revenues and earnings jump.
			INDUSTRY INNOVATION Conference stresses collaboration.

GOVERNMENT & POLICY
			GOVERNMENT CONCENTRATES
			ENVIRONMENTAL ADVISER As chairman of the Council on Environmental Quality, James Connaughton helps guide policy.
			PEER REVIEW AT NIH Overhaul creates new set of study sections.
			INSIGHTS Legislative measures to fix the asbestos legal morass are long overdue.

SCIENCE/TECHNOLOGY
			SCIENCE/TECHNOLOGY CONCENTRATES
			NEW ZEOLITES Researchers use common reagents to synthesize novel products.
			JACS AT 125 George S. Hammond explained structure-reactivity relationships in organic reactions.
			C&EN TALKS WITH James Trevelyan discusses the urgent problems in humanitarian demining.
			WHAT'S THAT STUFF? Jell-O's primary ingredient, gelatin, gives the dessert its appeal.
			DIGITAL BRIEFS New Software And Websites For The Chemical Enterprise

BOOKS
			THE ENIGMATIC ROSALIND FRANKLIN

EMPLOYMENT
			OPPORTUNITY KNOCKS Public- and private-sector jobs abound for the non-Ph.D. chemist.

THE DEPARTMENTS
		EDITOR'S PAGE
		LETTERS
		NEWSCRIPTS

ACSNEWS
			HISTORIC LANDMARK Research Triangle Institute lab is honored for the discovery of revolutionary anticancer drugs.
			C&EN ONLINE EXCLUSIVES
			OFFICIAL REPORTS FROM THE NEW ORLEANS MEETING
			ACS ACCEPTS GIFT FROM PENICILLIN PIONEER
PEOPLE
			OBITUARIES